158 related articles for article (PubMed ID: 27450638)
1. Impact of paraaortic lymphadenectomy for endometrial cancer with positive pelvic lymph nodes: A Korean Radiation Oncology Group study (KROG 13-17).
Yoon MS; Park W; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Chang SK; Lee KK; Kim M; Jeong JU; Nam TK
Eur J Surg Oncol; 2016 Oct; 42(10):1497-505. PubMed ID: 27450638
[TBL] [Abstract][Full Text] [Related]
2. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17).
Yoon MS; Park W; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Chang SK; Lee KK; Kim M
Gynecol Oncol; 2015 Sep; 138(3):519-25. PubMed ID: 26115977
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma.
Yoon MS; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Lee KK; Kim M; Jeong JU; Chang SK; Park W
Cancer Res Treat; 2016 Jul; 48(3):1074-83. PubMed ID: 26511800
[TBL] [Abstract][Full Text] [Related]
4. Paraaortic lymphadenectomy in intermediate to high risk uterine endometrioid cancer : a retrospective evaluation.
Tsikouras P; Koukouli Z; Zervoudis S; Manav B; Iatrakis G; Liberis A; Galazios G; Alexander Teichmann T
J BUON; 2016; 21(5):1158-1167. PubMed ID: 27837618
[TBL] [Abstract][Full Text] [Related]
5. Is there any benefit of paraaortic field irradiation in pelvic lymph node positive endometrial cancer patients? A propensity match analysis.
Onal C; Yuce Sari S; Akkus Yildirim B; Gultekin M; Guler OC; Yildiz F
J Obstet Gynaecol; 2020 Oct; 40(7):1012-1019. PubMed ID: 31793400
[TBL] [Abstract][Full Text] [Related]
6. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
7. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
8. Pretherapeutic staging of locally advanced cervical cancer: Inframesenteric paraaortic lymphadenectomy accuracy to detect paraaortic metastases in comparison with infrarenal paraaortic lymphadenectomy.
Azaïs H; Ghesquière L; Petitnicolas C; Borghesi Y; Tresch-Bruneel E; Cordoba A; Narducci F; Bresson L; Leblanc E
Gynecol Oncol; 2017 Nov; 147(2):340-344. PubMed ID: 28919265
[TBL] [Abstract][Full Text] [Related]
9. Analysis of outcome of Stage I-III endometrial cancer treated with systematic operation omitting paraaortic lymphadenectomy.
Kyo S; Hashimoto M; Maida Y; Mizumoto Y; Nakamura M; Takakura M; Inoue M
Eur J Gynaecol Oncol; 2007; 28(3):170-3. PubMed ID: 17624080
[TBL] [Abstract][Full Text] [Related]
10. Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?
Bottke D; Wiegel T; Kreienberg R; Kurzeder C; Sauer G
Strahlenther Onkol; 2007 Nov; 183(11):600-4. PubMed ID: 17960334
[TBL] [Abstract][Full Text] [Related]
11. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis.
Todo Y; Kato H; Kaneuchi M; Watari H; Takeda M; Sakuragi N
Lancet; 2010 Apr; 375(9721):1165-72. PubMed ID: 20188410
[TBL] [Abstract][Full Text] [Related]
12. Para-aortic lymph node dissection for women with endometrial adenocarcinoma and intermediate- to high-risk tumors: does it improve survival?
Courtney-Brooks M; Scalici JM; Tellawi AR; Cantrell LA; Duska LR
Int J Gynecol Cancer; 2014 Jan; 24(1):91-6. PubMed ID: 24362716
[TBL] [Abstract][Full Text] [Related]
13. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
14. Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.
Sozen H; Çiftçi R; Vatansever D; Topuz S; Iyibozkurt AC; Bozbey HU; Yaşa C; Çali H; Yavuz E; Kucucuk S; Aydiner A; Salihoglu Y
Aust N Z J Obstet Gynaecol; 2016 Apr; 56(2):199-206. PubMed ID: 26890292
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic Collaboration.
Mayadev J; Elshaikh MA; Christie A; Nagel C; Kennedy V; Khan N; Lea J; Ghanem A; Miller D; Xie XJ; Folkert M; Albuquerque K
Am J Clin Oncol; 2018 Dec; 41(12):1220-1224. PubMed ID: 29683799
[TBL] [Abstract][Full Text] [Related]
16. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
[TBL] [Abstract][Full Text] [Related]
17. Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment.
Aloisi A; Casanova JM; Tseng JH; Seader KA; Nguyen NT; Alektiar KM; Makker V; Chiang S; Soslow RA; Leitao MM; Abu-Rustum NR
Gynecol Oncol; 2018 Dec; 151(3):395-400. PubMed ID: 30286945
[TBL] [Abstract][Full Text] [Related]
18. Patterns of recurrence in endometrial cancer patients at risk of lymph node metastasis or recurrence according to extent of lymphadenectomy.
Kim HJ; Kim TJ; Song T; Kim MK; Lee YY; Choi CH; Lee JW; Bae DS; Kim BG
Int J Gynecol Cancer; 2012 May; 22(4):611-6. PubMed ID: 22398712
[TBL] [Abstract][Full Text] [Related]
19. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
20. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]